Integrating In Vitro Kinetic Data from Compounds Exhibiting Induction, Reversible Inhibition and Mechanism-Based Inactivation: In Vitro Study Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|5|2|141-146

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.5, Iss.2, 2004-01, pp. : 141-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Drug Interactions via Mechanism-Based Cytochrome P450 Inactivation: Points to Consider for Risk Assessment from In Vitro Data and Clinical Pharmacologic Evaluation

By  

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 449-462

Bentham Science Publishers

Access to resources Recommend Favorite

A Critical Evaluation of the Experimental Design of Studies of Mechanism Based Enzyme Inhibition, with Implications for In Vitro-In Vivo Extrapolation

By  

Current Drug Metabolism, Vol. 7, Iss. 3, 2006-04 ,pp. : 315-334

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inhibition of Zinc Proteases

By  

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 959-965

Bentham Science Publishers

Access to resources Recommend Favorite

Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 3, 2014-01 ,pp. : 297-303

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions Arising From Mechanism-Based Inactivation: Key Input Parameters and Impact on Risk Assessment

By  

Current Drug Metabolism, Vol. 12, Iss. 9, 2011-11 ,pp. : 871-890

Bentham Science Publishers

Access to resources Recommend Favorite